EMJ Oncology 11 [Supplement 2] . 2023

In this issue

As the potential of biosimilars continues to be explored by the medical community, robust real-world evidence is becoming more important in guiding informed decision-making. This article summarised the current real-world evidence relating to biosimilar use across breast and lung cancer.